Jeremy has over 30 years of experience in the pharmaceutical industry and over 20 years working in Regulatory Affairs in the US and Europe.

He has extensive experience and significant knowledge for product development strategies at all stages of a product life cycle and across many therapeutic areas that include Ophthalmology, Oncology, Rheumatology, CNS, Dermatology, Diabetes, Pain Management and Osteoporosis.

Prior to Novitious, Jeremy held Regulatory leadership roles at Hoffman-LaRoche, Novartis and Sirion and most recently at Point Guard Partners as VP of Regulatory Affairs.

His significant regulatory accomplishments include submission, approval and management of more than 10 INDs, 15 NDAs; 10 MAA’s, 20 IND/CTA’s, and 3 Orphan Drug applications.